Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Plasma homocysteine levels in systemic lupus erythematosus].
Martínez-Berriotxoa A, Ruiz-Irastorza G, Egurbide Arberas MV, Rueda Gutiérrez M, Aguirre Errasti C. Martínez-Berriotxoa A, et al. Med Clin (Barc). 2003 May 17;120(18):681-5. doi: 10.1016/s0025-7753(03)73812-3. Med Clin (Barc). 2003. PMID: 12781093 Spanish.
Vitamin supplementation and risk of stroke.
Aguirre C, Ruiz-Irastorza G, Egurbide MV, Martinez-Berriotxoa A. Aguirre C, et al. JAMA. 2004 May 12;291(18):2191; author reply 2191-2. doi: 10.1001/jama.291.18.2191-a. JAMA. 2004. PMID: 15138233 No abstract available.
[The antiphospholipid syndrome in the 21st century].
Ruiz-Irastorza G, Martinez-Berriotxoa A, Egurbide MV. Ruiz-Irastorza G, et al. Med Clin (Barc). 2009 Sep 19;133(10):390-6. doi: 10.1016/j.medcli.2008.10.046. Epub 2009 Apr 16. Med Clin (Barc). 2009. PMID: 19375117 Review. Spanish.
Predictors of major infections in systemic lupus erythematosus.
Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C. Ruiz-Irastorza G, et al. Arthritis Res Ther. 2009;11(4):R109. doi: 10.1186/ar2764. Epub 2009 Jul 15. Arthritis Res Ther. 2009. PMID: 19604357 Free PMC article.
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases.
Ramos-Casals M, García-Hernández FJ, de Ramón E, Callejas JL, Martínez-Berriotxoa A, Pallarés L, Caminal-Montero L, Selva-O'Callaghan A, Oristrell J, Hidalgo C, Pérez-Alvarez R, Micó ML, Medrano F, Gómez de la Torre R, Díaz-Lagares C, Camps M, Ortego N, Sánchez-Román J; BIOGEAS Study Group. Ramos-Casals M, et al. Clin Exp Rheumatol. 2010 Jul-Aug;28(4):468-76. Epub 2010 Aug 30. Clin Exp Rheumatol. 2010. PMID: 20525449
Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C, Croca S, Sangle S, Vital EM, Catapano F, Martínez-Berriotxoa A, García-Hernández F, Callejas-Rubio JL, Rascón J, D'Cruz D, Jayne D, Ruiz-Irastorza G, Emery P, Isenberg D, Ramos-Casals M, Khamashta MA; UK-BIOGEAS Registry. Díaz-Lagares C, et al. Autoimmun Rev. 2012 Mar;11(5):357-64. doi: 10.1016/j.autrev.2011.10.009. Epub 2011 Oct 18. Autoimmun Rev. 2012. PMID: 22032879
265 results